The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical contract services for drug development and manufacturing.

Founded

1996

Deals · 12mo

0

Stage focus

Series D

Geographic focus

United States

Sector focus

Biopharma
Biotechnology
Health Care
Manufacturing

Investment portfolio

1rounds
NAMEDATESIZE
Absci
Jan 2020Led
$15 MSeries D
Absci
Jan 2020Led
$15 MSeries D
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

KBI Biopharma: 1 funding rounds are recorded in the selected participation categories.All available history.
KBI Biopharma: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series C+10

Monthly Deal Activity

KBI Biopharma: 1 deals are recorded across 82 months.All available history.
KBI Biopharma: 1 deals are recorded across 82 months. All available history
MonthDeals
Jan '201
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

KBI Biopharma: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

KBI Biopharma: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1
AI & Machine Learning1

Deal Size Distribution

KBI Biopharma: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

KBI Biopharma: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

KBI Biopharma: United States has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

KBI Biopharma: United States has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
United States1
KBI Biopharma: 5 co-investors are shown, with Columbia Ventures Corporation sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

KBI Biopharma: 5 co-investors are shown, with Columbia Ventures Corporation sharing 1 recorded deals. All available history
Co-investorShared deals
Columbia Ventures Corporation1
JSR Life Sciences1
Oregon Venture Fund1
Phoenix Venture Partners1
WRF Capital1

Investment Strategy

KBI Biopharma: Led accounts for 100% and participating for 0% of round participation.All available history.
KBI Biopharma: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
KBI Biopharma: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
KBI Biopharma: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Abhinav Shukla

Sr. Vice President, Process Development and Manufacturing

Doris Michor

Chief Operating Officer

Jean Baptiste Agnus

Chief Business Officer

Jesse Kingg

VP Manufacturing & Site Head Commercial Mfg. Facility

Marykay Marchigiani

Chief Financial Officer

Niket Bubna

Associate Director

Sigma Mostafa

Chief Scientific Officer

Véronique Lessines

Head Of Quality Assurance